Related Experiment Videos
Polymerase processivity and termination on Drosophila heat shock genes
1Section of Biochemistry, Molecular and Cell Biology, Cornell University, Ithaca, New York 14853.
The Journal of Biological Chemistry
|November 15, 1993
Summary
The drug 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) inhibits RNA polymerase II transcription. This study reveals DRB affects transcription differently than natural pausing at the hsp70 gene, suggesting distinct regulatory mechanisms.
Area of Science:
- Molecular Biology
- Gene Regulation
- Biochemistry
Background:
- RNA polymerase II transcription is regulated at multiple steps.
- The drug 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) is known to inhibit transcription.
- The Drosophila hsp70 gene exhibits a paused polymerase at its 5'-end in the uninduced state.
Purpose of the Study:
- To investigate the mechanism of DRB-induced transcriptional pausing.
- To compare DRB-sensitive steps with the natural pausing of polymerase at the hsp70 gene.
- To analyze the polymerase termination process at the hsp26 gene.
Main Methods:
- In vivo UV cross-linking.
- KMnO4 hyperreactive site mapping.
- Polymerase-DNA cross-linking.
Main Results:
- DRB treatment allows transcription to proceed beyond the naturally paused polymerase site at hsp70.
- DRB treatment reduces hyper-reactivity in regions associated with open polymerase and early elongation complexes.
- Polymerase termination at the hsp26 gene occurs at multiple downstream sites.
Conclusions:
- The DRB-sensitive transcriptional block is distinct from the natural pausing mechanism at the hsp70 gene's 5'-end.
- DRB likely targets a polymerase modification step affecting early elongation.
- Multiple termination sites exist downstream of the polyadenylation signal for hsp26.